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Modulation of homing properties of primitive
progenitor cells generated by ex vivo expansion
There is considerable interest in ex vivoexpansion procedures to improvethe efficiency and broaden the clini-
cal use of hematopoietic stem cell (HSC)
transplantation. Although large amplifica-
tion of committed progenitors is readily
achieved under current ex vivo culture pro-
tocols, only modest expansion of trans-
plantable stem cells has been reported.1,2
Several lines of evidence indicate that HSC
execute self-renewal divisions and there-
fore expand in culture using optimal combi-
nations of early acting cytokines. Using cell
tracking procedures, it was shown that the
majority of non-obese diabetic severe com-
bined immune-deficient (NOD/SCID) mice
repopulating cells (SRC) harvested from
short-term expansion cultures were the
progeny of cells that had executed at least
one division.3 Other reports documented
efficient retroviral transduction of HSC in
ex vivo cultures4,5 which constitutes yet
more evidence of self-renewal division
since vector integration occurs in post-
mitotic cells.  Thus, the evidence of stem
cell proliferation in ex vivo culture must be
reconciled with the absence of their quanti-
tative expansion. It was hypothesized that
proliferating stem cells lack appropriate
engraftment capabilities to be detected in
xenogeneic transplantation assays. In sup-
port of this view, there is evidence of cell
cycle-related changes in the engraftment
capacity of adult and neonatal stem cells.6-9
Consequently, primitive hematopoietic
cells harvested after self-renewal division
ex vivo might interact differently with lig-
ands of the bone marrow (BM) microenvi-
ronment, as compared with their uncul-
tured counterparts. The present study was
undertaken to directly examine the validity
of this hypothesis. Anatomical stem cell
localization is mediated by multiple BM
ligands. Stem cell homing to the bone mar-
row involves rolling on endothelial E- and
P-selectins,10,11 firm adhesion to vascular cell
Background and Objectives. The maintenance of adequate interactions with the bone
marrow (BM) microenvironment is critical to ensure efficient homing of ex vivo-expand-
ed hematopoietic cells. This study was intended to assess adhesion and migration
properties of long-term culture-initiating cells (LTC-IC) harvested after self-renewal divi-
sion in ex vivo culture and to determine their susceptibility to growth-inhibitory signals
mediated by adhesion to BM stromal ligands. 
Design and Methods. We used cell tracking to isolate primitive LTC-IC that had accom-
plished 1 or 2 divisions ex vivo. Adhesion, migration and growth inhibition of divided LTC-
IC were determined in the presence of purified BM ligands, and compared to the prop-
erties of uncultured LTC-IC. 
Results. As compared to undivided LTC-IC, adhesion and migration mediated by very
late antigen (VLA)-4 integrin across both vascular cell adhesion molecule-1 (VCAM-1)
and fibronectin (Fn) were downregulated in post-mitotic LTC-IC. Conversely, binding and
motility via VLA-5 across Fn were stimulated. No changes occurred in LTC-IC interactions
with intercellular adhesion molecule-1 (ICAM-1) or with E- or P-selectin. Proliferation of
uncultured LTC-IC was inhibited by VLA-4-mediated binding to VCAM-1 and the CS-1
domain of Fn, as well as binding to P-selectin. Growth of ex vivo-generated LTC-IC
became unresponsive to these 3 ligands but was suppressed through VLA-5 engage-
ment by the cell binding domain of Fn.
Interpretations and Conclusions. The generation of LTC-IC in expansion culture is asso-
ciated with functional alterations of adhesion receptors, modulating not only binding
and migration in the BM but also responsiveness to adhesion-mediated growth inhibito-
ry signals. Such changes may limit homing and engraftment of expanded primitive
stem/progenitor cells.
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adhesion molecule–1 (VCAM-1) and intercellular
adhesion molecule-1 (ICAM-1), followed by trans-
endothelial migration via very late antigen (VLA)-4
(α4β1 integrin) binding to VCAM-1 as well as VLA-4
and VLA-5 (α5β1) adhesion to Fn.12 Directed migration
across BM endothelial and stromal cells is dependent
on the chemokine stromal-derived factor-1 (SDF-1).13,14
Intracellular signals triggered by engagement of adhe-
sion receptors play an important role in controlling
progenitor proliferation.15 Adhesion to fibronectin (Fn)
and P-selectin inhibits the cycling of progenitor cells,
through engagement of VLA-416 and P-selectin glyco-
protein ligand-1 (PSGL-1),17 respectively. Stimulation of
adhesion receptors expressed by BM-homed cells may
be critical in controlling the balance between quies-
cence and proliferation in the post-transplantation
period.18
In this report, mobilized peripheral blood (PB)
hematopoietic cells with long term culture-initiation
potential were isolated after self-renewal division ex
vivo, by high resolution cell tracking. Adhesion and
migration interactions with stromal ligands were stud-
ied. Furthermore, the effect of adhesion on primitive
progenitor cell proliferation was also determined.
Design and Methods
Hematopoietic cell isolation
After obtaining informed consent, mobilized PB
samples were collected from normal adult volunteers
according to the guidelines established by the Ethical
Committee of the University of Liège. Mobilization
was achieved by daily granulocyte-colony stimulating
factor (G-CSF; Amgen, Brussels, Belgium), administra-
tion at 10 µg/kg for 5 consecutive days. Cells were col-
lected by apheresis on day 5. PB CD133+ cells were
isolated by immunomagnetic selection using CD133
CliniMACS columns (Miltenyi Biotech, Bergisch
Gladbach, Germany). The purity of selected cells was
measured according to the manufacturer’s protocol
and always exceeded 95%. Cells were cryopreserved
in liquid nitrogen in small aliquots in 90% fetal bovine
serum (FBS; Invitrogen) and 10% dimethylsulfoxide
(Sigma, Bornem, Belgium).
Short-term cultures and cell division tracking
Cell samples were rapidly thawed at 37°C, exten-
sively washed in phosphate-buffered saline (PBS;
Biowhittaker, Verviers, Belgium) supplemented with
1% calf serum (CS; Biowhittaker) and resuspended in
1 mL solution of 5 µmol/L carboxy fluorescein diac-
etate succinimidyl ester (CFSE; Molecular Probes,
Leiden, The Netherlands) in PBS. After a 10-minute
incubation at 37°C, cell staining was stopped by the
addition of 9 mL ice-cold PBS 20% FBS. Cells were
washed twice and resuspended in Iscoves’ medium
(Biowhittaker) supplemented with 20% BIT serum
substitute (Stem Cell Technologies, Meylan, France)
before undergoing a preparative sort. This consisted in
selecting a homogeneous population of CFSE-stained
cells using a narrow gate of 40-channel width in order
to increase subsequent resolution of cell divisions, as
previously described.3
CFSE-stained CD133+ cells were used as such in
downstream assays of long-term culture-initiating cells
(LTC-IC) adhesion, migration or growth inhibition (see
below) or were plated in short-term expansion culture
in Iscove’s medium supplemented with 20% BIT, 2
mmol/L alanyl-glutamine, 1% (v/v) cholesterol-rich
lipids, 1 mmol/L sodium pyruvate (all from Sigma),
100 U/mL penicillin, 100 µg/mL streptomycin and
5×10-2 mmol/L 2-mercaptoethanol (all from Bio-
whittaker). In culture, cells were stimulated for 72
hours by a combination of 100 ng/mL each of stem cell
factor (SCF), thrombopoietin (TPO; both from Amgen)
and flt-3 ligand (FL; Peprotech, Boechout, Belgium)
and 20 ng/mL of interleukin-6 (IL-6; Amgen) and G-
CSF. To identify undivided cells, 50 ng/mL colcemid
(Sigma) were added to control cultures to block cell
division. Cells that had undergone 1 or 2 divisions
were sorted according to the dilution of CFSE staining,
using gates separated by at least 50 channels to pre-
vent cross-contamination. The purity of sorted frac-
tions was always >90%. One and 2-division LTC-IC
were characterized in adhesion, migration and prolif-
eration inhibition assays as described below.
LTC-IC adhesion assays
Purified ligands were coated in 12-well plates at the
following concentrations: fibronectin fragments CH-
296 (RetronectinTM), H-296 or C-274 (kindly provided
by Takara Bio Inc., Otsu Shiga, Japan) at 9 µg/cm2,
human E- or P-selectin at 2 µg/cm2, human recombi-
nant VCAM-1 or ICAM-1 (all from R&D Systems,
Abingdon, U.K.) at 1 µg/cm2 or 2% fraction V BSA
(Invitrogen, Paisley, UK) in PBS. Up to 105 CD133+ cells
were plated in Iscoves’ medium 20% BIT for 1h at
37°C. Non-adherent cells were harvested by standard-
ized washes using warm PBS 1% BSA and discarded.
Adherent cells were overlayed with 60×103 unirradiat-
ed MS-5 cells,19 in 1.5 mL Myelocult (Stem Cell
Technologies). Control long-term cultures of input
cells (adherent + non-adherent) were initiated with
1/10 of the original cell suspension plated in ligand-
coated dishes in 1.5 mL Myelocult. Cultures were
maintained at 33°C in 5% CO2 with weekly changes
of half the medium. After 5 weeks, cultures were
trypsinized and the cell suspension was transferred in
duplicate progenitor assays in a semi-solid medium
consisting of 0.9% methylcellulose (Stem Cell
Technologies), 30% FBS, 10% 5637 bladder carcinoma
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cell line conditioned medium, 3 U erythropoietin
(Janssen-Cilag, Beerse, Belgium), 50 mmol/L 2-mercap-
toethanol, 200 mmol/L L-glutamine, 100 U/mL peni-
cillin and 100 µg/mL streptomycin in Iscoves’ medium.
After an additional 2-week incubation, secondary
colony-forming cells, hereafter called LTC-CFC, were
scored using standard criteria. The percentage of LTC-
IC adhesion on each ligand was calculated, as previ-
ously described,20 as the number of LTC-CFC harvest-
ed from long-term cultures initiated with adherent
cells divided by the number of LTC-CFC produced by
input cells × 10.
LTC-IC migration assays
LTC-IC migration assays were performed as previ-
ously described20,21 in 6.5-mm diameter 5-µm pore
Transwells (Costar, Elscolab, Kruibeke, Belgium).
Transwell filters were coated with purified ligands as
listed above. Control filters were coated with 2% frac-
tion V BSA in PBS. Up to 104 CD133+ cells were plated
in 100 µL Iscoves’ medium 20% BIT in the upper
chamber of the Transwell. The bottom compartment
was filled with 600 µL of conditioned medium from
the murine stromal cell line MS-5 (MS-5 CM), pre-
pared exactly as described previously.22 After incuba-
tion at 37°C for 3 hours, the Transwell was dismantled
and non-migrating cells were discarded. Migrating
cells were transferred to 12-well plates seeded 24
hours previously with 60×103 unirradiated MS-5 cells
in 1.5 mL Myelocult. Control long-term cultures of
input cells (migrating + non-migrating) were initiated
with 1/10 of the original cell suspension incubated in
MS-5 CM for 3 hours in ligand-coated dishes and then
overlayed with MS-5 cells in 1.5 mL Myelocult. LTC-
IC activity was measured as described above. The per-
centage of LTC-IC migration across each ligand was
defined as the number of LTC-CFC harvested from
long-term cultures initiated with migrating cells divid-
ed by the number of LTC-CFC produced by input cells
× 10. 
Assessment of LTC-IC growth inhibition
CFSE-stained CD133+ cells were incubated in plates
coated with different purified ligands as described
above, or 2% BSA as control. Cells were cultured for 7
days in complete medium supplemented with low cyto-
kine concentrations (1 ng/mL each of SCF, TPO and FL,
and 200 pg/mL each of G-CSF and IL-6). Progeny cells
were overlayed with unirradiated MS-5 cells to initiate
bulk LTC-IC assays. Long-term cultures and secondary
progenitor assays were carried out as described above.
Alternatively, CFSE-labeled CD133+ cells were first
stimulated in uncoated plates in complete medium sup-
plemented with high concentrations of cytokines, i.e.,
100 ng/mL each of SCF, TPO and FL and 20 ng/mL of IL-
6 and G-CSF. After 3 days, 1 and 2-division cells were
sorted, washed and transferred to plates coated with
purified ligands or 2% BSA in low cytokine concentra-
tions for an additional 7 days. LTC-IC output of proge-
ny cells was assessed as described above. 
Statistical analysis
Results are reported as mean ± standard error of the
mean (SEM). Comparisons were made using two-
tailed Student’s t-tests. 
Results
Self-renewal divisions of LTC-IC in short-term culture
It has been previously reported that a small but sig-
nificant proportion of progenitor cells, endowed with
primitive hematopoietic properties, is resistant to
cytokine stimulation for up to 7 days in expansion cul-
tures supplemented with combinations of IL-3, SCF
and/or IL-6.23,24 More recent studies using additional
early acting cytokines such as FL and TPO have
demonstrated that the vast majority of progenitor
cells, including the most primitive subset, respond to
short-term growth factor stimulation3,25 To monitor cell
divisions in asynchronously proliferating CD133+ cells
in culture, we used cell tracking with CFSE as depict-
ed in Figure 1. After 72 hours in culture, 60.2±0.5,
27.9±0.6 and 3.5±0.4% of expanded cells had execut-
ed 1, 2 or 3 divisions, respectively. Undivided cells rep-
resented 8.4±0.4% of harvested cells at this time point
(Figure 1B). After an additional 24 hours of culture,
most of the cells had reached the 2- or 3-division stage
(Figure 1C). In order to obtain maximal proportions of
cells that had divided once or twice, a 72-hour culture
duration was chosen for all experiments. Average
increase in total cell number was 2.7 fold at this time
point. One- and 2-division cells were then separated
by flow cytometric cell sorting (Figure 1). LTC-IC
activity of unstimulated CD133+ cells was determined
and compared to that of 1- and 2-division cells.
Uncultured CD133+ cells yielded 28.5±0.5 week 5
LTC-CFC per 100 input cells while 1- and 2-division
cells produced 27.9±1.1 and 28.9±1.2 week 5 LTC-
CFC per 100 input cells, respectively (n=8). Thus, LTC-
IC were quickly induced to proliferate and executed
self-renewal divisions in these culture conditions. 
Alterations of adhesion receptor function in
ex vivo-generated LTC-IC
Adhesion and migration properties of LTC-IC were
determined in CFSE-stained CD133+ cells without any
prior cytokine stimulation and compared to those of
cells having undergone 1 or 2 divisions in short-term
suspension cultures. Static binding to Fn fragment CH-
296 (RetronectinTM), which comprises binding sites for
both VLA-4 and VLA-5 integrins, was observed in
Adhesion receptors in expanded progenitor cells
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19.7±0.6% of unstimulated LTC-IC (Figure 2). To dis-
tinguish the contribution of VLA-4 and VLA-5 in medi-
ating interaction with Fn, we used Fn fragments H-296
and C-274. Using specific blocking antibodies it has
been previously established that H-296 is specific for
VLA-4 and C-274 is specific for VLA-5.26,27 Un-
stimulated LTC-IC adhered to Fn mainly via the VLA-
4 binding site as demonstrated by higher binding to Fn
fragment H-296 (28.3±2.6%) than to the VLA-5 bind-
ing fragment C-274 (10±1.6% adhesion). Adhesion to
immobilized E-selectin was observed in 24.3±2.5% of
unstimulated LTC-IC while static adhesion to P-
selectin was not detectable. Adhesion to VCAM-1 and
ICAM-1 was 33.5±4.8% and 19.8±2.9%, respectively. 
Activation of VLA-5 was observed for LTC-IC gen-
erated by ex vivo self-renewal divisions, resulting in a
significant rise in adhesion capacity to C-274, both
after 1 and 2 divisions (p<0.05, Figure 2). Conversely,
VLA-4 function was downmodulated since binding of
1- or 2-division LTC-IC to H-296 and to VCAM-1 was
significantly decreased (p<0.05). Inactivation of VLA-4
did not result in defective binding to CH-296. Finally,
binding of LTC-IC to E- and P-selectin, as well as to
ICAM-1 was not different in divided LTC-IC and in
their uncultured counterparts. 
Migration properties of ex vivo-generated LTC-IC
Migration of LTC-IC across stromal ligands was
determined in Transwell assays in which cells were
stimulated to migrate toward medium conditioned by
Figure 1. Cell tracking of peripheral blood
CD133+ cells in expansion cultures. A. FACS
profile of CFSE-stained peripheral blood
CD133+ cells before culture. B. After culture
for 3 days with SCF, FL, TPO, G-CSF and IL-6,
successive cell generations were identified as
indicated on top of each peak. A control cul-
ture in the presence of colcemid was used as
reference for undivided cells. C. CFSE his-
togram after an additional 24 hours in cul-
ture, showing the progression of cell prolifera-
tion. Adhesion, migration and growth inhibi-
tion assays were carried out in uncultured
cells and in cells having executed 1 and 2 divi-
sions after 3 days in culture.
Figure 2. Changes in binding properties of LTC-IC generated ex
vivo. LTC-IC adhesion was determined on Fn fragments CH-296, H-
296 and C-274, E-selectin (E-sel.), P-selectin (P-sel.), VCAM, ICAM
and BSA. Adhesion was assessed in unmanipulated LTC-IC or after
1 or 2 divisions executed in expansion cultures. *p<0.05 com-
pared to adhesion of uncultured LTC-IC on the same ligand (n=4).
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Figure 3. Migration of LTC-IC produced in ex vivo cultures.
Migration was determined in Transwells coated with the same
series of ligands as used in adhesion assays (see Figure 2), in
uncultured LTC-IC or in LTC-IC harvested after 1 or 2 divisions in
culture. *p<0.05 compared to migration of uncultured LTC-IC
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the stromal cell line MS-5 (MS-5 CM). We and others
have previously shown that chemotaxis of primitive
progenitors toward MS-5 CM is dependent on an SDF-
1/CXCR-4 interaction.21,22 Migration of unstimulated
LTC-IC was optimally stimulated by CH-296 (52.8±
3.63%) and VCAM-1 (43.4±4.3%) (Figure 3). Similarly
to regulation of static binding to Fn, VLA-4 was more
active than VLA-5 in supporting the motility of
unstimulated LTC-IC since migration across H-296
(35.7±2.4%) was higher than across C-274 (11.4±2.6%
migration). E-selectin (22.2±3.2%) and ICAM-1
(20.5±0.2% migration) were mildly effective in medi-
ating motility of uncultured LTC-IC. Finally, transmi-
gration through P-selectin did not differ significantly
from control migration across BSA. Inactivation of
VLA-4  in 1- and 2-division LTC-IC was demonstrated
by decreased transmigration through both H-296 Fn
fragment and VCAM-1 (p<0.05). Increased motility
across C-274 indicated activation of VLA-5 (p<0.05).
Transmigration across CH-296 was significantly
reduced in divided LTC-IC. Since CH-296 carries bind-
ing sites for both VLA-4 and VLA-5, this suggests the
predominant role of VLA-4 integrin in mediating LTC-
IC motility across Fn. Migration through ICAM-1 was
slightly reduced in divivided LTC-IC while no change
occurred in LTC-IC migration through E- and P-
selectins after ex vivo cell division (Figure 3).
The control of hematopoiesis by adhesion-mediated
signals is altered in ex vivo-generated LTC-IC 
Adhesion receptors are not only important for stem
cell localization and trafficking but they also play a
major role in regulating the hematopoietic process
itself through the activation of signals influencing cell
survival and growth. We investigated the effect of
adhesive interactions on LTC-CFC production by
uncultured and ex vivo-generated CD133+ cells using
the experimental design depicted in Figure 4. Fresh
CFSE-labeled CD133+ cells were cultured for 7 days
onto immobilized BM ligands or control BSA and in
physiological cytokine concentrations28 after which the
LTC-CFC output was assessed. Baseline LTC-CFC pro-
duction after incubation in BSA-coated plates was on
average 104.5±7.3 LTC-CFC per 100 cells plated at the
start of the 7-day culture period. The effect of adhesion
on BM ligands was expressed relative to control cul-
tures on BSA. When cultured on CH-296 Fn fragment,
LTC-CFC output was inhibited by 48±8% (p<0.05),
consistently with previous reports16 (Figure 5). The
inhibition of hematopoiesis by Fn was mainly due to
cell binding via VLA-4 integrin since H-296 mediated a
56±8% inhibition (p<0.05) in LTC-CFC output where-
as binding to C-274 via VLA-5 had no such effect
(12±3% inhibition, p>0.05). We also observed that
binding to P-selectin could suppress primitive progeni-
tor cell expansion (21±1% inhibition, p<0.05), as previ-
ously reported by Levesque and colleagues.17 In addi-
tion, a 19±5% inhibition (p<0.05 versus control BSA
cultures) in LTC-CFC output was observed when cells
were incubated on VCAM-1. E-selectin and ICAM-1
had no significant effect on primitive progenitor cell
development under these conditions. 
We next investigated whether adhesion-mediated
growth inhibitory signals were still operating after a
prior expansion step in the absence of any adhesive
ligand (Figure 4). To this end, PB CD133+ cells were
expanded in suspension culture for 3 days with high
cytokine concentrations. At this time point, LTC-CFC
output by 1- and 2-division CD133+ cells (the two pop-
ulations were pooled in these experiments) was
28.4±1.0 per 100 cells. The cells were then transferred
to plates coated with stromal ligands or control BSA
for an additional 7 days. In BSA-coated plates, LTC-
CFC production increased to 96.6±3.8 per 100 input
cells. In ligand-coated plates, significant alterations in
adhesion-mediated suppression of hematopoiesis
were observed (Figure 5). CH-296 still inhibited LTC-
CFC output, although this effect was less pronounced
(32±2% inhibition) than on unstimulated cells
(p<0.05). Importantly, suppression of hematopoiesis
by Fn in cultured LTC-IC was then mainly mediated
by VLA-5 and not by VLA-4 integrin as demonstrated
by the lack of effect provided by H-296 (13±6% inhi-
bition, p<0.05) and the activation of C-274-mediated
inhibition (40±1%, p<0.05 compared to undivided
Figure 4. Control of LTC-CFC generation by BM stromal ligands:
experimental design. Freshly thawed CD133+ cells were plated in
ligand-coated dishes and incubated for one week in medium sup-
plemented with low growth factor (GF) concentrations (1 ng/mL
each of SCF, TPO and FL, and 200 pg/mL each of G-CSF and IL-6).
Alternatively, cells were stimulated for 3 days in suspension cul-
ture with high GF concentrations before being transferred to lig-
and-coated dishes for an additional week in low GF. LTC-CFC pro-
duction ([LTC]) was measured by overlaying input CD133+ cells or
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LTC-IC). Furthemore, expanded LTC-IC became unre-
sponsive to the inhibitory effects of P-selectin and
VCAM-1.
Collectively, these data suggest that changes in the
activation state of adhesion receptors in ex vivo-generat-
ed primitive progenitor cells not only affect their adhe-
sion and migration capacity, but also modify their
response to signals critical for the control of hemato-
poiesis by the bone marrow microenvironment.
Discussion
In the present study, we demonstrate that after self-
renewal division in short-term culture, there were
major alterations in the interactions of LTC-IC with
BM stromal ligands and in their response to adhesion-
mediated growth-inhibitory signals. 
We observed an activation of VLA-5-mediated adhe-
sion to Fn in 1- or 2-division LTC-IC, whereas VLA-4-
mediated binding was inactivated. We previously
reported a similar switch in integrin usage prior to any
cell division in synchronized cultures of progenitor
cells undergoing a first cell cycle transit in ex vivo cul-
ture.20 Thus it appears that this functional inversion is
independent of cell division in itself but is rather asso-
ciated with ex vivo stimulation with high concentra-
tions of mitogenic cytokines and persist at least up to
2 completed cell cycles. As expected from the adhe-
sion assays, transmigration through the VLA-4 binding
Fn fragment H-296 was downregulated after ex vivo
division whereas migration across the VLA-5 binding
Fn fragment C-274 increased in expanded LTC-IC.
Binding and transmigration on VCAM-1 were signifi-
cantly downregulated in ex vivo-generated LTC-IC,
mostly after 2 divisions. This is further indication of a
functional inactivation of α4 integrin. Conversely, no
major changes were observed in the interactions with
ICAM-1, except for a modest decrease in transmigra-
tion through ICAM-1-coated Transwells. Also, bind-
ing and transmigration across E- and P-selectins were
not different in ex vivo-generated LTC-IC and in their
unstimulated counterparts. 
Given the pivotal role of adhesion to VCAM-129 and
Fn12,26,30 in stem cell localization, the present study sup-
ports the notion that otherwise functionnally intact
primitive progenitor cells may accomplish self-renew-
al divisions in ex vivo suspension cultures but display a
defective homing capacity. Our data further indicate
that homing alterations may be mainly located in the
final intramedullary steps of BM implantation, i.e. dur-
ing stem/progenitor cell lodgment in specific endosteal
niches,30 whereas initial marrow seeding through inter-
actions with endothelial selectins and ICAM-1 is pre-
served. 
We also provide evidence that inhibitory signals
mediated by integrin engagement are modified after
LTC-IC self-renewal division ex vivo. It has been well
established by Verfaillie and co-workers that engage-
ment of Fn receptors suppresses hematopoietic pro-
genitor cell proliferation.28 In accordance with the pres-
ent study, it has also been demonstrated that inhibi-
tion of progenitor cell proliferation by Fn binding is
dependent on VLA-4 under low cytokine conditions.16
Our data further demonstrate that LTC-IC obtained by
ex vivo expansion under pharmacological concentra-
tions of stimulatory cytokines are responsive to sup-
pressive signals mediated by VLA-5 while VLA-4-
mediated inhibition is downmodulated. Contact with
VCAM-1 inhibited LTC-IC in unstimulated cells but
not in expanded cells which is further evidence of
VLA-4 inactivation. It has been demonstrated that
inhibition of hematopoiesis by integrin engagement is
due to a block in S phase entry28 and is associated with
elevated levels of cyclin-dependent kinase inhibitor
p27KIP1. Our data suggest that this response is elicited
by engagement of VLA-4. It remains to be established
whether LTC-IC inhibition mediated by VLA-5 and
observed after stimulation with supraphysiological
concentrations of cytokines occurs though the same
signaling pathway. In conclusion, our data indicate a
dissociation between self-renewal properties and
maintenance of physiological interactions with the
BM stroma, in primitive progenitor cells produced in
vitro. Future efforts should be directed at optimizing
Figure 5. Inhibition of LTC-IC activity by stromal ligands before and
after expansion culture. Peripheral blood CD133+ cells were
manipulated as described in Figure 4. Data represent % inhibition
of LTC-CFC production by indicated ligands relative to cells incu-
bated in BSA-coated plates. The effect of stromal ligands on uncul-
tured LTC-IC or on 1- and 2-division LTC-IC was assessed (n=3).
*LTC-CFC output was significantly decreased by the indicated lig-
and (p<0.05) as compared to cells incubated in BSA-coated
plates; #inhibition of LTC-IC activity by the indicated ligand was
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culture conditions which drive stem cell self-renewal
divisions while maintaining engraftment potential.
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